Predictions
Lumen Technologies Inc.
Start price
Target price
Perf. (%)
€10.01
31.01.21
31.01.21
-
31.01.22
31.01.22
3.65%
08.02.21
08.02.21
Hanesbrands Inc.
Start price
Target price
Perf. (%)
€12.50
31.01.21
31.01.21
-
31.01.22
31.01.22
14.52%
01.02.22
01.02.22
Risky balance sheet
Increased challenges to pay loans and raise capital
Electronic Arts Inc.
Start price
Target price
Perf. (%)
€118.38
31.01.21
31.01.21
€131.00
31.01.22
31.01.22
-0.74%
01.02.22
01.02.22
Microsoft Corp.
Start price
Target price
Perf. (%)
€191.80
30.01.21
30.01.21
€186.00
30.01.22
30.01.22
44.86%
30.01.22
30.01.22
Alphabet Inc. C
Start price
Target price
Perf. (%)
€76.12
30.01.21
30.01.21
-
30.01.22
30.01.22
30.20%
03.06.21
03.06.21
Very capable Management
Leading role in innovation
Good culture
Strong uniques
Salesforce.com
Start price
Target price
Perf. (%)
€186.98
30.01.21
30.01.21
€270.00
30.01.22
30.01.22
6.86%
31.01.22
31.01.22
Could be very worthwhile Investment >20% year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€274.60
29.01.21
29.01.21
€300.00
29.01.22
29.01.22
52.59%
30.01.22
30.01.22
Waste Management Inc.
Start price
Target price
Perf. (%)
€91.90
29.01.21
29.01.21
€105.00
29.01.22
29.01.22
44.72%
30.01.22
30.01.22
News Corp. B
Start price
Target price
Perf. (%)
€15.40
28.01.21
28.01.21
-
28.01.22
28.01.22
36.36%
10.06.21
10.06.21
Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Few uniques
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€282.25
28.01.21
28.01.21
€350.00
28.01.22
28.01.22
22.16%
02.07.21
02.07.21
Amazon.com Inc.
Start price
Target price
Perf. (%)
€135.88
28.01.21
28.01.21
€177.50
28.01.22
28.01.22
4.84%
09.08.21
09.08.21
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
CME Group Inc.
Start price
Target price
Perf. (%)
€149.98
28.01.21
28.01.21
-
28.01.22
28.01.22
34.88%
29.01.22
29.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected